{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:00:10Z","timestamp":1791568810451,"version":"4.3.4"},"reference-count":46,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"5381","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Science"],"published-print":{"date-parts":[[1998,8,28]]},"abstract":"<jats:p>Glutamatergic abnormalities have been associated with several psychiatric disorders, including schizophrenia and addiction. Group II metabotropic glutamate receptors were targeted to normalize glutamatergic disruptions associated with an animal model of schizophrenia, the phencyclidine model. An agonist of this group of receptors, at a dose that was without effects on spontaneous activity and corticolimbic dopamine neurotransmission, attenuated the disruptive effects of phencyclidine on working memory, stereotypy, locomotion, and cortical glutamate efflux. This behavioral reversal occurred in spite of sustained dopamine hyperactivity. Thus, targeting this group of receptors may present a nondopaminergic therapeutic strategy for treatment of psychiatric disorders.<\/jats:p>","DOI":"10.1126\/science.281.5381.1349","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:49:42Z","timestamp":1027763382000},"page":"1349-1352","source":"Crossref","is-referenced-by-count":841,"title":["Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats"],"prefix":"10.1126","volume":"281","author":[{"given":"Bita","family":"Moghaddam","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Yale University School of Medicine, Veterans Administration Medical Center 116A\/2, West Haven, CT 06516, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara W.","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale University School of Medicine, Veterans Administration Medical Center 116A\/2, West Haven, CT 06516, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0304-3940(80)90178-0","volume":"20","author":"Kim J. S.","year":"1980","unstructured":"Kim J. S., Kornhuber H. H., Schmid-Burgk W., Holzmuller B., Neurosci. Lett. 20, 379 (1980);","journal-title":"Neurosci. Lett."},{"key":"e_1_3_1_2_3","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1471-4159.1989.tb07257.x","volume":"52","author":"Deakin J. F. W.","year":"1989","unstructured":"Deakin J. F. W., et al., J. Neurochem. 52, 1781 (1989);","journal-title":"J. Neurochem."},{"key":"e_1_3_1_2_4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"Javitt D.","year":"1991","unstructured":"Javitt D., Zukin S., Am. J. Psychiatry 148, 1301 (1991);","journal-title":"Am. J. Psychiatry"},{"key":"e_1_3_1_2_5","unstructured":"; B. G. Bunney W. E. Bunney A. Carlsson in Psychopharmacology: The Fourth Generation of Progress F. E. Bloom and D. J. Kupfer Eds. (Raven New York 1995) pp. 1205\u20131214;"},{"key":"e_1_3_1_2_6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10673229609017192","volume":"3","author":"Coyle J.","year":"1996","unstructured":"Coyle J., Harvard Rev. Psychiatry 3, 241 (1996);","journal-title":"Harvard Rev. Psychiatry"},{"key":"e_1_3_1_2_7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.20","volume":"12","author":"Tamminga C. A.","year":"1998","unstructured":"Tamminga C. A., Crit. Rev. Neurobiol. 12, 21 (1998).","journal-title":"Crit. Rev. Neurobiol."},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1192\/bjp.157.3.459","volume":"157","author":"Deakin J. F. W.","year":"1990","unstructured":"Deakin J. F. W., Slater P., Simpson M. D. C., Royston M. C., Br. J. Psychiatry 157, 459 (1990);","journal-title":"Br. J. Psychiatry"},{"key":"e_1_3_1_3_3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/cercor\/2.6.503","volume":"2","author":"Benes F. M.","year":"1992","unstructured":"Benes F. M., et al., Cereb. Cortex 2, 503 (1992);","journal-title":"Cereb. Cortex"},{"key":"e_1_3_1_3_4","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","volume":"52","author":"Olney J. W.","year":"1995","unstructured":"Olney J. W., Farber N. B., Arch. Gen. Psychiatry 52, 998 (1995).","journal-title":"Arch. Gen. Psychiatry"},{"key":"e_1_3_1_4_2","first-page":"63","volume":"43","author":"Schmidt W. J.","year":"1994","unstructured":"Schmidt W. J., J. Neural Transm. Suppl. 43, 63 (1994).","journal-title":"J. Neural Transm. Suppl."},{"key":"e_1_3_1_4_3","first-page":"478","volume":"6","author":"Iversen S. D.","year":"1995","unstructured":"Iversen S. D., Behav. Pharmacol. 6, 478 (1995);","journal-title":"Behav. Pharmacol."},{"key":"e_1_3_1_4_4","unstructured":"; A. Carlsson A. Svensson M. L. Carlsson Future Strategies in the Discovery of New Antipsychotic Agents: Focus on Dopamine-Glutamate Interactions (Karger Basel Switzerland 1993) vol. 4 pp. 118\u2013129."},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","volume":"81","author":"Luby E. D.","year":"1959","unstructured":"Luby E. D., Cohen B. D., Rosenbaum G., Gottlieb J. S., Kelley R., Am. Med. Assoc. Arch. Neurol. Psychiatry 81, 363 (1959);","journal-title":"Am. Med. Assoc. Arch. Neurol. Psychiatry"},{"key":"e_1_3_1_5_3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"Krystal J. H.","year":"1994","unstructured":"Krystal J. H., et al., Arch. Gen. Psychiatry 51, 199 (1994);","journal-title":"Arch. Gen. Psychiatry"},{"key":"e_1_3_1_5_4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0893-133X(95)00137-3","volume":"14","author":"Malhotra A. K.","year":"1996","unstructured":"Malhotra A. K., et al., Neuropsychopharmacology 14, 301 (1996).","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","volume":"13","author":"Lahti A. C.","year":"1995","unstructured":"Lahti A. C., Koffel B., LaPorte D., Tamminga C. A., Neuropsychopharmacology 13, 9 (1995);","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_1_6_3","first-page":"141","volume":"17","author":"Malhotra A. K.","year":"1997","unstructured":"Malhotra A. K., et al., ibid. 17, 141 (1997).","journal-title":"ibid."},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0165-6147(93)90107-U","volume":"14","author":"Schoepp D. D.","year":"1993","unstructured":"Schoepp D. D., Conn P. J., Trends Pharmacol. Sci. 14, 13 (1993);","journal-title":"Trends Pharmacol. Sci."},{"key":"e_1_3_1_7_3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.bb.23.060194.001535","volume":"23","author":"Nakanishi S.","year":"1994","unstructured":"Nakanishi S., Masu M., Annu. Rev. Biophys. Biomol. Struct. 23, 319 (1994);","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"e_1_3_1_7_4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","volume":"37","author":"Conn P. J.","year":"1997","unstructured":"Conn P. J., Pin J.-P., Annu. Rev. Pharmacol. Toxicol. 37, 205 (1997) .","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0306-4522(95)00533-1","volume":"71","author":"Petralia R. S.","year":"1996","unstructured":"Petralia R. S., Wang Y.-X., Niedzielski A. S., Wenthold R. J., Neuroscience 71, 949 (1996).","journal-title":"Neuroscience"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(95)00119-6","volume":"277","author":"East S. J.","year":"1995","unstructured":"East S. J., Hill M. P., Brotchie J. M., Eur. J. Pharmacol. 277, 117 (1995);","journal-title":"Eur. J. Pharmacol."},{"key":"e_1_3_1_9_3","first-page":"111","volume":"116","author":"Foley P.","year":"1995","unstructured":"Foley P., Br. J. Pharmacol. 116, 111 (1995).","journal-title":"Br. J. Pharmacol."},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(97)00442-4","volume":"229","author":"Battaglia G.","year":"1997","unstructured":"Battaglia G., Monn J. A., Schoepp D. D., Neurosci. Lett. 229, 161 (1997).","journal-title":"Neurosci. Lett."},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1152\/jn.1995.73.3.1076","volume":"73","author":"Lovinger D. M.","year":"1995","unstructured":"Lovinger D. M., McCool B. A., J. Neurophysiol. 73, 1076 (1995);","journal-title":"J. Neurophysiol."},{"key":"e_1_3_1_11_3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0304-3940(96)12486-1","volume":"207","author":"Yoshino M.","year":"1996","unstructured":"Yoshino M., Sawada S., Yamamoto C., Kamiya H., Neurosci. Lett. 207, 70 (1996).","journal-title":"Neurosci. Lett."},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"Moghaddam B.","year":"1997","unstructured":"Moghaddam B., Adams B., Verma A., Daly D., J. Neurosci. 17, 2921 (1997).","journal-title":"J. Neurosci."},{"key":"e_1_3_1_13_2","first-page":"5545","volume":"18","author":"Adams B.","year":"1998","unstructured":"Adams B., Moghaddam B., ibid. 18, 5545 (1998).","journal-title":"ibid."},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0091-3057(93)90217-H","volume":"46","author":"Willins D. L.","year":"1993","unstructured":"Willins D. L., Narayanan S., Wallace L. J., Uretsky N. J., Pharmacol. Biochem. Behav. 46, 881 (1993);","journal-title":"Pharmacol. Biochem. Behav."},{"key":"e_1_3_1_14_3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF01271550","volume":"101","author":"Bubser M.","year":"1995","unstructured":"Bubser M., Tzschentke T., Hauber W., J. Neural Transm. Gen. Sect. 101, 115 (1995) .","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"e_1_3_1_15_2","unstructured":"A. Anand et al. Soc. Neurosci. Abstr. 23 686.3 (1997)."},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(96)00160-8","volume":"36","author":"Schoepp D. D.","year":"1997","unstructured":"Schoepp D. D., et al., Neuropharmacology 36, 1 (1997);","journal-title":"Neuropharmacology"},{"key":"e_1_3_1_16_3","first-page":"651","volume":"284","author":"Helton D. R.","year":"1998","unstructured":"Helton D. R., Tizzano J. P., Monn J. A., Schoepp D. D., Jeanne M., J. Pharmacol. Exp. Ther. 284, 651 (1998).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_1_17_2","unstructured":"Animals were treated with vehicle or LY354740 before they were injected with a moderate dose of PCP (1 and 5 mg\/kg ip injection). Measurements were made of (i) in vivo extracellular glutamate concentrations in the prefrontal cortex and nucleus accumbens (ii) in vivo extracellular dopamine concentrations in the prefrontal cortex and nucleus accumbens (iii) locomotor activity (iv) stereotypy and (v) performance in a T-maze discrete-trial delayed alternation task a rodent working memory paradigm. Animal use procedures were in accordance with the NIH Guide for the Care and Use of Laboratory Animals (National Institutes of Health Bethesda MD 1996) and were approved by the Yale University Animal Care and Use Committee. Microdialysis and behavioral measures were performed in awake freely moving rats (male Sprague-Dawley 275 to 325 g) as described in (12). Microdialysis and locomotor data were analyzed by repeated measures of analysis of variance (ANOVA). The delayed alternation data were compared by multifactorial ANOVA followed by Tukey post hoc analysis. Significance was set at P < 0.05."},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.npp.1380103","volume":"11","author":"Ogren S. O.","year":"1994","unstructured":"Ogren S. O., Goldstein M., Neuropsychopharmacology 11, 167 (1994).","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01258633"},{"key":"e_1_3_1_19_3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1098-2396(199610)24:2<135::AID-SYN5>3.0.CO;2-G","volume":"24","author":"Druhan J. P.","year":"1996","unstructured":"Druhan J. P., Rajabi H., Stewart J., Synapse 24, 135 (1996).","journal-title":"Synapse"},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/schbul\/16.3.391","volume":"16","author":"Robbins T. W.","year":"1990","unstructured":"Robbins T. W., Schizophr. Bull. 16, 391 (1990).","journal-title":"Schizophr. Bull."},{"key":"e_1_3_1_21_2","unstructured":"P. Goldman-Rakic in Psychopathology and the Brain B. J. Carroll and J. E. Barrett Eds. (Raven New York 1991) pp. 1\u201323."},{"key":"e_1_3_1_22_2","unstructured":"E. Bleuler Dementia Praecox or the Group of Schizophrenias (International Universities Press New York 1950);"},{"key":"e_1_3_1_22_3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0022-3956(86)90013-0","volume":"20","author":"Lyon N.","year":"1986","unstructured":"Lyon N., Mejsholm B., Lyon M., J. Psychiatr. Res. 20, 137 (1986) .","journal-title":"J. Psychiatr. Res."},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/15563657608988151","volume":"9","author":"Burns R. S.","year":"1976","unstructured":"Burns R. S., Lerner S. E., Clin. Toxicol. 9, 477 (1976).","journal-title":"Clin. Toxicol."},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","unstructured":"G. Tsai et al. Arch. Gen. Psychiatry 52 829 (1995).","DOI":"10.1001\/archpsyc.1995.03950220039008"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"B. Wroblewska et al. J. Neurochem. 69 174 (1997).","DOI":"10.1046\/j.1471-4159.1997.69010174.x"},{"key":"e_1_3_1_26_2","unstructured":"B. Moghaddam and B. W. Adams data not shown."},{"key":"e_1_3_1_27_2","unstructured":"We thank D. Schoepp for helpful discussions and for assisting us in obtaining LY354740 J. Aultman for technical assistance and the National Institute of Mental Health for supporting this research."}],"container-title":["Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/science.281.5381.1349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T03:18:06Z","timestamp":1705115886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/science.281.5381.1349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8,28]]},"references-count":46,"journal-issue":{"issue":"5381","published-print":{"date-parts":[[1998,8,28]]}},"alternative-id":["10.1126\/science.281.5381.1349"],"URL":"https:\/\/doi.org\/10.1126\/science.281.5381.1349","relation":{},"ISSN":["0036-8075","1095-9203"],"issn-type":[{"value":"0036-8075","type":"print"},{"value":"1095-9203","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8,28]]}}}